|This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.|
A product of the National Association of Specialty Pharmacy's (NASP) Center for Specialty Pharmacy Education(CSPE). View more NASP/CSPE Activities
Cellular and molecular information is building on our knowledge of physiology and organ systems and this expansion in our knowledge is facilitating the development of drugs and therapies that go beyond biochemistry and pharmacology. Market predictions point toward consistent growth in these therapies, which is going to require an understanding of cellular and molecular biology. This activity will briefly review key background information and definitions and then discuss gene therapy, disease-modifying treatments and patient considerations following therapy.
The target audience for this activity includes pharmacists. Upon completion of this activity, participants will be able to:
- Explain and broadly discuss key features of gene therapy, including the therapeutic mechanisms, and factors that can affect efficacy and durability.
- Summarize short- and long-term patient safety considerations following gene therapy.
- Differentiate disease-modifying treatments based on their durability, clinical efficacy, mechanism of action, and safety profile.
- Explain the therapeutic potential and current clinical limitations of CRISPR gene editing.
Rebecca L. Bigler, PhD
Chief Scientific Officer
Therapeutic Genetics Consulting Associates
It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants the existence of any significant financial interest or any other relationship with the manufacturer of any commercial product(s) discussed in an educational presentation. Rebecca Bigler has no relevant commercial and/or financial relationships to disclose.
Release Date: June 1, 2020
Expiration Date: June 1, 2023
This CE activity is jointly provided by ProCE, Inc. and the National Association of Specialty Pharmacy (NASP). ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-20-221-H01-P has been assigned to this knowledge-based, home-study activity. This CE activity is approved for 1.0 contact hour (0.1 CEU) in states that recognize ACPE providers. Completion of an evaluation and post-test with a score of 70% or higher is required to receive CE credit. Proof of completion will be posted in NABP CPE Monitor profiles. No partial credit will be given.
No external support has been received for this activity.
The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.